Plant secondary metabolites
such as flavonoids demonstrate high
degrees of antioxidant, anti-inflammatory, and anticancer activities.
Among flavonoids, quercetin plays an important role in inflammation
by downregulating the level of various cytokines. Thereby, in this
work, onion (Allium cepa) peel was
successfully utilized for the synthesis of gold nano-bioconjugates
acting as a natural therapeutic drug. In this process, crude onion
peel extract was first divided into different fractionates, namely,
ethyl acetate, butanol, methanol, and water, and they were subjected
to various preliminary studies of antioxidant activities. The ethyl
acetate fractionate shows high antioxidant activities in all the assays.
The bioactive components were identified and found to contain a high
amount of quercetin as confirmed by liquid chromatography with tandem
mass spectrometry and high-performance liquid chromatogrpahy. Three
gold nano-bioconjugates were prepared with different concentrations
of the ethyl acetate fractionate. Various biochemical anti-inflammatory
assays were carried out and compared with the active ethyl acetate
fraction of the onion peel drug (OPD). The cytotoxicity of the nano-bioconjugate
system and the OPD was checked in the myoblast L6 cell line from skeletal
muscle tissues to evaluate the toxicity. All the three nano-bioconjugates
A, B, and E demonstrated high percentages of cell viability, viz.,
73.07, 72.3, and 69.15%, respectively, at their highest concentration
of 200 μg/mL. The OPD also showed 88.56% cell viability with
no toxic effects in the myoblast L6 cell line from skeletal muscle
tissues. The reactive oxygen species reduction of nano-bioconjugate
B showed a marked reduction of 76.77% at a maximum concentration of
200 μg/mL, whereas the OPD showed 68.17%. Hence, through this
work, a cheap source of nano-bioconjugates is developed, which can
act as a potent antioxidant and anti-inflammatory agent and are more
active in comparison to the OPD alone.